SCHEMBL1424949

SCHEMBL1424949

COc1cc(C(=O)O)cnc1CC(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA4 P22748 2/20 0.45
CA6 P23280 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
PKM P14618 2/20 0.45
CA3 P07451 1/20 0.45
CA5A P35218 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
TSHR P16473 2/20 0.44
TPMT P51580 2/20 0.44
PTGS2 P35354 1/20 0.42
HTT P42858 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.40
HCAR3 P49019 2/20 0.39
HCAR2 Q8TDS4 1/20 0.39
XDH P47989 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1179055 0.80 HCAR3 (0.42) HCAR3HCAR2XDHKDM4EALDH1A1
SCHEMBL1424892 0.80 HCAR3 (0.42) HCAR3HCAR2XDHKDM4EALDH1A1
SCHEMBL13260598 0.78 HCAR3 (0.41) HCAR3HCAR2KDM4EALDH1A1KMT2A
Hydrochloric Acid SCHEMBL1425630 0.78 HCAR3 (0.41) HCAR3HCAR2XDHKDM4EALDH1A1
Hydrochloric Acid SCHEMBL1425521 0.78 HCAR3 (0.41) HCAR3HCAR2XDHKDM4EALDH1A1
Hydrochloric Acid SCHEMBL3730343 0.77 HCAR3 (0.40) HCAR3HCAR2KDM4EALDH1A1KMT2A
SCHEMBL1425096 0.76 HCAR3 (0.39) PKMTSHRHCAR3HCAR2XDH
SCHEMBL27553339 0.76 CA12 (0.56) CA12CA1CA2CA4CA6
SCHEMBL3956689 0.75 XDH (0.49) HCAR3HCAR2XDHALDH1A1
SCHEMBL1424904 0.74 HCAR3 (0.40) HCAR3HCAR2KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8598208-B2 Pyridine derivatives as S1P1/EDG1 receptor modulators ACTELION PHARMACEUTICALS LTD. (CH) 2013-12-03 US disclosed
US-20110212998-A1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD. (CH) 2011-09-01 US disclosed
EP-2195311-B1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2011-03-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212998-A1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS S1PR1, S1PR3, S1PR2 CA12 4871/4885CA1 4827/4885CA2 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.